Works matching IS 20050380 AND DT 2024 AND VI 35 AND IP 2

Results: 19

The 8th Biennial Meeting of the Asian Society of Gynecologic Oncology, December 1st to 3rd, 2023.

Published in:

Journal of Gynecologic Oncology, 2024, v. 35, n. 2, p. 1, doi. 10.3802/jgo.2024.35.e67

By:

Heng-Cheng Hsu;
Jae-Weon Kim;
Jeong-Yeol Park;
Dong Hoon Suh;
Se Ik Kim;
Jen-Ruei Chen;
Peng-Hui Wang

Publication type:

Article

Major clinical research advances in gynecologic cancer in 2023: a tumultuous year for endometrial cancer.

Published in:

Journal of Gynecologic Oncology, 2024, v. 35, n. 2, p. 1, doi. 10.3802/jgo.2024.35.e66

By:

Seung-Hyuk Shim;
Jung-Yun Lee;
Yoo-Young Lee;
Jeong-Yeol Park;
Yong Jae Lee;
Se Ik Kim;
Gwan Hee Han;
Eun Jung Yang;
Noh, Joseph J.;
Ga Won Yim;
Joo-Hyuk Son;
Nam Kyeong Kim;
Tae-Hyun Kim;
Tae-Wook Kong;
Youn Jin Choi;
Cho, Angela;
Hyunji Lim;
Eun Bi Jang;
Hyun Woong Cho;
Dong Hoon Suh

Publication type:

Article

Evolving standards and future directions for systemic therapies in cervical cancer.

Published in:

Journal of Gynecologic Oncology, 2024, v. 35, n. 2, p. 1, doi. 10.3802/jgo.2024.35.e65

By:

Ang, Daniel Jia Ming;
Chan, Jack Junjie

Publication type:

Article

Simple hysterectomy SHAPE-ing up to be the treatment of choice for early cervical cancer under 2 cm.

Published in:

Journal of Gynecologic Oncology, 2024, v. 35, n. 2, p. 1, doi. 10.3802/jgo.2024.35.e49

By:

Benseler, Anouk;
Covens, Allan

Publication type:

Article

Challenges and perspectives on less invasive surgery for early-stage cervical cancer: a critical analysis of the SHAPE trial and its implications.

Published in:

Journal of Gynecologic Oncology, 2024, v. 35, n. 2, p. 1, doi. 10.3802/jgo.2024.35.e48

By:

Munetaka Takekuma

Publication type:

Article

Is it time to change surgery for early-stage low-risk cervical cancer to simple hysterectomy?

Published in:

Journal of Gynecologic Oncology, 2024, v. 35, n. 2, p. 1, doi. 10.3802/jgo.2024.35.e47

By:

Jeong-Yeol Park

Publication type:

Article

Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology consensus statement.

Published in:

Journal of Gynecologic Oncology, 2024, v. 35, n. 2, p. 1, doi. 10.3802/jgo.2024.35.e45

By:

Ju-Hyun Kim;
Dae-Yeon Kim;
Junhwan Kim;
Noh, Joseph J.;
Woo Yeon Hwang;
Min-Hyun Baek;
Min Chul Choi;
Won Duk Joo;
Yong Jae Lee;
Dong Hoon Suh;
Yong Beom Kim

Publication type:

Article

Clinical practice guidelines for cervical cancer: the Korean Society of Gynecologic Oncology guidelines.

Published in:

Journal of Gynecologic Oncology, 2024, v. 35, n. 2, p. 1, doi. 10.3802/jgo.2024.35.e44

By:

Ji Geun Yoo;
Sung Jong Lee;
Eun Ji Nam;
Jae Hong No;
Jeong Yeol Park;
Jae Yun Song;
So-Jin Shin;
Bo Seong Yun;
Sung Taek Park;
San-Hui Lee;
Dong Hoon Suh;
Yong Beom Kim;
Taek Sang Lee;
Jae Man Bae;
Keun Ho Lee

Publication type:

Article

Analysis of East Asia subgroup in Study 309/KEYNOTE-775: lenvatinib plus pembrolizumab versus treatment of physician's choice chemotherapy in patients with previously treated advanced or recurrent endometrial cancer.

Published in:

Journal of Gynecologic Oncology, 2024, v. 35, n. 2, p. 1, doi. 10.3802/jgo.2024.35.e40

By:

Kan Yonemori;
Keiichi Fujiwara;
Kosei Hasegawa;
Mayu Yunokawa;
Kimio Ushijima;
Shiro Suzuki;
Ayumi Shikama;
Shinichiro Minobe;
Tomoka Usami;
Jae-Weon Kim;
Byoung-Gie Kim;
Peng-Hui Wang;
Ting-Chang Chang;
Keiko Yamamoto;
Shirong Han;
McKenzie, Jodi;
Orlowski, Robert J.;
Takuma Miura;
Makker, Vicky;
Yong Man Kim

Publication type:

Article

LncRNA linc01194 promotes the progress of endometrial carcinoma by up-regulating SOX2 through binding to IGF2BP1.

Published in:

Journal of Gynecologic Oncology, 2024, v. 35, n. 2, p. 1, doi. 10.3802/jgo.2024.35.e21

By:

Zhenghao Huang;
Fan Shen;
Jingwen Chen;
Bumin Xie;
Xi Chen;
Yang Zhao;
Shuo Chen

Publication type:

Article

Cervical screening among Chinese females in the era of HPV vaccination: a population-based survey on screening uptake and regular screening following an 18-year organized screening program.

Published in:

Journal of Gynecologic Oncology, 2024, v. 35, n. 2, p. 1, doi. 10.3802/jgo.2024.35.e20

By:

Choi, Horace C. W.;
Leung, Kathy;
Wu, Joseph T.

Publication type:

Article

Study of neoadjuvant chemotherapy in advanced malignant ovarian germ cell tumors at a tertiary center in western India.

Published in:

Journal of Gynecologic Oncology, 2024, v. 35, n. 2, p. 1, doi. 10.3802/jgo.2024.35.e19

By:

Vasanth, Abhilash;
Patel, Shilpa M.;
Arora, Ruchi;
Parekh, Chetana D.;
Dave, Pariseema;
Patel, Bijal M.;
Vemanamandhi, Priyanka

Publication type:

Article

Regularity of cervical cancer screening in Korea: analysis using national public data for 12 years.

Published in:

Journal of Gynecologic Oncology, 2024, v. 35, n. 2, p. 1, doi. 10.3802/jgo.2024.35.e18

By:

Jong-Yeup Kim;
Jeeyoung Hong;
Juhee Yoon;
Jinsol Park;
Tae-Hyun Kim

Publication type:

Article

A machine learning-based prediction model of pelvic lymph node metastasis in women with early-stage cervical cancer.

Published in:

Journal of Gynecologic Oncology, 2024, v. 35, n. 2, p. 1, doi. 10.3802/jgo.2024.35.e17

By:

Monthatip, Kamonrat;
Boonnag, Chiraphat;
Muangmool, Tanarat;
Charoenkwan, Kittipat

Publication type:

Article

Adjuvant carboplatin and paclitaxel with "sandwich" method radiotherapy for stage III or IV endometrial cancer: long-term follow-up at a single-institution.

Published in:

Journal of Gynecologic Oncology, 2024, v. 35, n. 2, p. 1, doi. 10.3802/jgo.2024.35.e16

By:

Chinnadurai, Anu;
Breadner, Daniel;
Baloush, Ziad;
Lohmann, Ana Elisa;
Black, Morgan;
D'Souza, David;
Welch, Stephen

Publication type:

Article

Feasibility of laparoscopic Visceral-Peritoneal Debulking (L-VPD) in patients with stage III-IV ovarian cancer: the ULTRA-LAP trial pilot study.

Published in:

Journal of Gynecologic Oncology, 2024, v. 35, n. 2, p. 1, doi. 10.3802/jgo.2024.35.e14

By:

Tozzi, Roberto;
Noventa, Marco;
Saccardi, Carlo;
Spagnol, Giulia;
De Tommasi, Orazio;
Coldebella, Davide;
Marchetti, Matteo

Publication type:

Article

Cisplatin-induced PANDAR-Chemo-EVs contribute to a more aggressive and chemoresistant ovarian cancer phenotype through the SRSF9-SIRT4/SIRT6 axis.

Published in:

Journal of Gynecologic Oncology, 2024, v. 35, n. 2, p. 1, doi. 10.3802/jgo.2024.35.e13

By:

Hao Wang;
Yinuo Li;
Yanan Wang;
Xiumin Shang;
Zhongxin Yan;
Shengli Li;
Wei Bao

Publication type:

Article

Mesothelin expression in gynecologic carcinosarcoma: clinicopathological significance and correlation with HER2 expression.

Published in:

Journal of Gynecologic Oncology, 2024, v. 35, n. 2, p. 1, doi. 10.3802/jgo.2024.35.e11

By:

Rui Kitadai;
Tadaaki Nishikawa;
Hiroshi Yoshida;
Chiharu Mizoguchi;
Kasumi Yamamoto;
Tomoyasu Kato;
Kan Yonemori

Publication type:

Article

Robotic or laparoscopic pelvic exenteration for gynecological malignancies: feasible options to open surgery.

Published in:

Journal of Gynecologic Oncology, 2024, v. 35, n. 2, p. 1, doi. 10.3802/jgo.2024.35.e12

By:

Dudus, Laura;
Minciuna, Corina;
Tudor, Stefan;
Lacatus, Monica;
Stefan, Bogdan;
Vasilescu, Catalin

Publication type:

Article